Predicting the Risk of Secondary Malignancies Associated With Pelvic Nodal Irradiation in the Treatment of Prostate Cancer

被引:0
|
作者
Jain, A. K. [1 ]
Shuryak, I. [2 ]
Ng, J. [1 ]
Chao, K. S. [1 ]
Brenner, D. J. [2 ]
Deutsch, I. [1 ]
机构
[1] Columbia Univ, Med Ctr, Dept Radiat Oncol, New York, NY USA
[2] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA
关键词
D O I
10.1016/j.ijrobp.2012.07.982
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S372 / S372
页数:1
相关论文
共 50 条
  • [21] Phase II trial of pelvic nodal irradiation with hypofractionated IMRT-SIB for high-risk prostate cancer
    Magli, A.
    Ceschia, T.
    Moretti, E.
    Signor, M.
    Polsinelli, M.
    Prisco, A.
    Crespi, M.
    Foti, C.
    Malisan, M. R.
    Fongione, S.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S91 - S91
  • [22] Ultra hypofractionated extended nodal irradiation using volumetric modulated arc therapy for oligorecurrent pelvic nodal prostate cancer
    Slevin, Finbar
    Thompson, Christopher M.
    Speight, Richard
    Murray, Louise J.
    Lilley, John
    Henry, Ann M.
    MEDICAL DOSIMETRY, 2021, 46 (04) : 411 - 418
  • [23] Prophylactic pelvic nodal RT vs only prostate bed irradiation in patients with prostatic cancer
    Fuentes, T.
    Calistri, E.
    Sainato, A.
    Manfredi, B.
    Matteucci, F.
    Morganti, R.
    Pasqualetti, F.
    Paiar, F.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1160 - S1160
  • [24] Elective pelvic nodal irradiation for elderly patients with high-risk prostate cancer: A more patient-oriented approach
    Iori, Federico
    Augugliaro, Matteo
    Ali, Emanuele
    Iotti, Cinzia
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2025, 51
  • [26] PROSTATE CANCER RISK VARIANTS ASSOCIATED WITH SUSCEPTIBILITY TO OTHER MALIGNANCIES
    Helfand, Brian T.
    Loeb, Stacy
    Kan, Donghui
    Meeks, Joshua J.
    Le, Brian
    Hofer, Matthias D.
    Banks, Jessica A.
    Cooper, Phillip R.
    Catalona, William J.
    JOURNAL OF UROLOGY, 2010, 183 (04): : E38 - E38
  • [27] Risk of second malignancies after prostate irradiation?
    Mueller, Arndt-Christian
    Ganswindt, Ute
    Bamberg, Michael
    Belka, Claus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (11) : 605 - 609
  • [28] Is pelvic irradiation still justified in the treatment of prostate cancer by exclusive radiotherapy?
    Chapet, O.
    Quero, L.
    Azria, D.
    Bossi, A.
    Hennequin, C.
    Paparel, P.
    CANCER RADIOTHERAPIE, 2009, 13 (05): : 416 - 422
  • [29] Pelvic nodal dose escalation in conjunction with hypofractionated IMRT for high risk prostate cancer
    Adkison, J. B.
    Patel, R. R.
    Bentzen, S. M.
    Hong, T. S.
    McHaffie, D. R.
    Ritter, M. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S305 - S305
  • [30] Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy
    Okajima, Kaoru
    Ishikawa, Kazuki
    Matsuura, Tomohiro
    Tatebe, Hitoshi
    Fujiwara, Kazuhisa
    Hiroi, Keiji
    Hasegawa, Hirokazu
    Nishimura, Yasumasa
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (06) : 1078 - 1084